vs

Side-by-side financial comparison of Lakeside Holding Ltd (LSH) and SWK Holdings Corp (SWKH). Click either name above to swap in a different company.

SWK Holdings Corp is the larger business by last-quarter revenue ($8.7M vs $7.0M, roughly 1.2× Lakeside Holding Ltd). On growth, Lakeside Holding Ltd posted the faster year-over-year revenue change (95.0% vs -29.7%).

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

SWK Holdings Corp is a specialty finance firm focused on the healthcare and life sciences sectors. It provides tailored financing solutions including royalty monetization, structured debt, and asset-backed lending to biotech, pharmaceutical, medical device and diagnostic companies, with its core market centered in North America.

LSH vs SWKH — Head-to-Head

Bigger by revenue
SWKH
SWKH
1.2× larger
SWKH
$8.7M
$7.0M
LSH
Growing faster (revenue YoY)
LSH
LSH
+124.7% gap
LSH
95.0%
-29.7%
SWKH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LSH
LSH
SWKH
SWKH
Revenue
$7.0M
$8.7M
Net Profit
$-1.6M
$-19.4M
Gross Margin
27.2%
Operating Margin
-21.3%
9.9%
Net Margin
-22.6%
Revenue YoY
95.0%
-29.7%
Net Profit YoY
18.7%
-430.2%
EPS (diluted)
$-0.08
$-1.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LSH
LSH
SWKH
SWKH
Q4 25
$7.0M
$8.7M
Q3 25
$6.1M
$10.9M
Q2 25
$6.3M
$10.1M
Q1 25
$3.8M
$11.8M
Q4 24
$3.6M
$12.4M
Q3 24
$4.1M
$10.4M
Q2 24
$10.8M
Q1 24
$11.4M
Net Profit
LSH
LSH
SWKH
SWKH
Q4 25
$-1.6M
$-19.4M
Q3 25
$-1.4M
$8.8M
Q2 25
$-893.1K
$3.5M
Q1 25
$-1.1M
$4.5M
Q4 24
$-1.9M
$5.9M
Q3 24
$-1.3M
$3.5M
Q2 24
$3.7M
Q1 24
$468.0K
Gross Margin
LSH
LSH
SWKH
SWKH
Q4 25
27.2%
Q3 25
18.2%
Q2 25
26.7%
Q1 25
18.8%
Q4 24
-1.2%
Q3 24
12.8%
Q2 24
Q1 24
Operating Margin
LSH
LSH
SWKH
SWKH
Q4 25
-21.3%
9.9%
Q3 25
-20.8%
61.3%
Q2 25
-8.9%
46.1%
Q1 25
-28.2%
68.6%
Q4 24
-55.6%
44.7%
Q3 24
-32.5%
39.2%
Q2 24
8.3%
Q1 24
9.5%
Net Margin
LSH
LSH
SWKH
SWKH
Q4 25
-22.6%
Q3 25
-22.2%
80.7%
Q2 25
-14.2%
35.2%
Q1 25
-28.2%
38.4%
Q4 24
-54.1%
47.5%
Q3 24
-32.7%
33.3%
Q2 24
33.9%
Q1 24
4.1%
EPS (diluted)
LSH
LSH
SWKH
SWKH
Q4 25
$-0.08
$-1.59
Q3 25
$-0.09
$0.72
Q2 25
$-0.11
$0.29
Q1 25
$-0.14
$0.37
Q4 24
$-0.26
$0.47
Q3 24
$-0.18
$0.28
Q2 24
$0.30
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LSH
LSH
SWKH
SWKH
Cash + ST InvestmentsLiquidity on hand
$1.6M
$42.8M
Total DebtLower is stronger
$2.4M
$33.0M
Stockholders' EquityBook value
$12.2M
$235.1M
Total Assets
$24.3M
$272.4M
Debt / EquityLower = less leverage
0.20×
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LSH
LSH
SWKH
SWKH
Q4 25
$1.6M
$42.8M
Q3 25
$4.5M
$10.2M
Q2 25
$5.0M
$8.0M
Q1 25
$1.5M
$29.8M
Q4 24
$1.1M
$5.9M
Q3 24
$2.7M
$17.2M
Q2 24
$5.5M
Q1 24
$5.5M
Total Debt
LSH
LSH
SWKH
SWKH
Q4 25
$2.4M
$33.0M
Q3 25
$2.4M
$33.0M
Q2 25
$1.4M
$33.0M
Q1 25
$774.2K
$33.0M
Q4 24
$784.8K
$33.0M
Q3 24
$589.9K
$33.0M
Q2 24
$33.0M
Q1 24
$33.0M
Stockholders' Equity
LSH
LSH
SWKH
SWKH
Q4 25
$12.2M
$235.1M
Q3 25
$7.0M
$254.2M
Q2 25
$2.8M
$246.5M
Q1 25
$749.8K
$292.7M
Q4 24
$1.6M
$288.7M
Q3 24
$3.6M
$283.4M
Q2 24
$282.8M
Q1 24
$279.9M
Total Assets
LSH
LSH
SWKH
SWKH
Q4 25
$24.3M
$272.4M
Q3 25
$18.6M
$289.4M
Q2 25
$14.4M
$285.7M
Q1 25
$9.9M
$331.3M
Q4 24
$9.8M
$332.2M
Q3 24
$10.8M
$321.3M
Q2 24
$321.0M
Q1 24
$322.0M
Debt / Equity
LSH
LSH
SWKH
SWKH
Q4 25
0.20×
0.14×
Q3 25
0.35×
0.13×
Q2 25
0.48×
0.13×
Q1 25
1.03×
0.11×
Q4 24
0.48×
0.11×
Q3 24
0.16×
0.12×
Q2 24
0.12×
Q1 24
0.12×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LSH
LSH
SWKH
SWKH
Operating Cash FlowLast quarter
$-453.5K
$27.3M
Free Cash FlowOCF − Capex
$26.8M
FCF MarginFCF / Revenue
308.1%
Capex IntensityCapex / Revenue
5.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$43.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LSH
LSH
SWKH
SWKH
Q4 25
$-453.5K
$27.3M
Q3 25
$-4.0M
$906.0K
Q2 25
$-483.7K
$7.8M
Q1 25
$-238.3K
$8.3M
Q4 24
$-530.2K
$23.0M
Q3 24
$-1.4M
$6.3M
Q2 24
$5.4M
Q1 24
$4.4M
Free Cash Flow
LSH
LSH
SWKH
SWKH
Q4 25
$26.8M
Q3 25
$557.0K
Q2 25
$-497.4K
$7.7M
Q1 25
$8.2M
Q4 24
$-560.5K
$22.9M
Q3 24
$-1.4M
$6.3M
Q2 24
$5.4M
Q1 24
FCF Margin
LSH
LSH
SWKH
SWKH
Q4 25
308.1%
Q3 25
5.1%
Q2 25
-7.9%
77.0%
Q1 25
69.1%
Q4 24
-15.6%
185.3%
Q3 24
-34.5%
60.4%
Q2 24
49.7%
Q1 24
Capex Intensity
LSH
LSH
SWKH
SWKH
Q4 25
5.9%
Q3 25
3.2%
Q2 25
0.2%
0.6%
Q1 25
0.0%
0.8%
Q4 24
0.8%
1.1%
Q3 24
0.1%
0.3%
Q2 24
0.2%
Q1 24
0.0%
Cash Conversion
LSH
LSH
SWKH
SWKH
Q4 25
Q3 25
0.10×
Q2 25
2.21×
Q1 25
1.82×
Q4 24
3.93×
Q3 24
1.82×
Q2 24
1.47×
Q1 24
9.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

SWKH
SWKH

Finance Receivables Segment$8.4M96%
Other$329.0K4%

Related Comparisons